Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media

Pediatric Infectious Disease Journal

Volumn 15, Issue 2, 1996, Pages 157-164

  Gooch III, W Manford ^a   Blair, Elizabeth ^b   Puopolo, Anthony ^c   Zorba Paster, R ^d   Schwartz, Richard H ^e   Charles Miller, H ^f   Lee Smyre, H ^g   Yetman, Robert ^h   Giguere, Gregory G ⁱ   Collins, Jeffrey J ⁱ  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Raleigh Neurology Associates   (United States)

^c Milford Emergency Associates   (United States)

^d DEAN MEDICAL CENTER   (United States)

^e Vienna Pediatric Associates   (United States)

^f Doctor's Medical Center   (United States)

^g Greer Pediatric Clinic   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ GLAXOSMITHKLINE   (United States)

Author keywords

acute otitis media; Cefuroxime axetil; short course therapy

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME AXETIL; CLAVULANIC ACID;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MULTICENTER STUDY; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE; VOMITING;

ACUTE DISEASE; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CEFUROXIME; CHILD; CHILD, PRESCHOOL; CLAVULANIC ACIDS; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALE; OTITIS MEDIA; PRODRUGS; PROSPECTIVE STUDIES; SUSPENSIONS; TREATMENT OUTCOME;

EID: 9044251970     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199602000-00013     Document Type: Article

References (28)

1. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS. General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin Infect Dis 1992;15(Suppl 1):S62-88.
2. Teele DW, Klein JO, Rosner B, The Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160:83-94.
3. Lisby-Sutch SM, Nemec-Dwyer MA, Deeter RG, Gaur SN. Therapy of otitis media. Clin Pharm 1990;9:15-34.
4. Hendrickse WA, Kusmiesz H, Shelton S, Nelson JD. Five vs. ten days of therapy for acute otitis media. Pediatr Infect Dis J 1988;7:14-23.
5. Portier H, Chavanet P, Gouyon JB, Guetat F. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother 1990;26:79-85.
6. Portier H, Chavanet P, Waldner-Combernoux A, et al. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Scand J Infect Dis 1994;26:59-66.
7. Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and Augmentin® in the treatment of upper respiratory tract infections. Drugs Exp Clin Res 1987;2:91-4.
8. Stromberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988;20:37-46.
9. Pichichero ME, Gooch WM, Rodriguez W, et al. Effective short-course treatment of acute Group A beta-hemolytic streptococcal tonsillopharyngitis. Arch Pediatr Adolesc Med 1994;148:1053-60.
10. Contardi I. Comparative open study of amoxicillin/clavulanic acid (AAC) vs cefuroxime axetil (CAE) in children [Abstract 220]. In: Selected abstracts presented at the Eighth Mediter- ranean Congress of Chemotherapy, Athens, Greece, May 24 to 29, 1992, Greenford, UK: Glaxo, 1992.
11. Esposito S, Noviello S, D'Errico G, Montanaro C. Cefuroximeaxetil (CXM-AX) versus Augmentin (AMC) in bacterial infections of the middle ear [Abstract 1342]. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, October 21 to 24, 1990.
12. Pichichero M, Aronovitz GH, Gooch WM, et al. Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children. South Med J 1990;83:1174-7.
13. McLinn SE, Moskal M, Goldfarb J, et al. Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother 1994;38:315-8.
14. Roge J, Durand B, Pappo M. Treatment of ENT infections with cefuroxime axetil: comparative study versus an amoxycillin/clavulanic acid combination in specialized general practice (in French). J Fr Oto-Rhino-Laryngol 1989;38:138-43.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Villanova, PA: National Committee for Clinical Laboratory Standards, 1983.
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA: National Committee for Clinical Laboratory Standards, 1988.
17. Finn A, Straughn A, Meyer M, Chubb J. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Dispos 1987;8:519-26.
18. Gooch WM, McLinn SE, Aronovitz GH, et al. Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob Agents Chemother 1993;37:159-63.
19. Marcucci L, Paternesi A. Infections of the upper respiratory tract: Italian clinical trial on the use of cefuroxime axetil [in Italian]. Riv Patol Sper Clin 1990;30:19-26.
20. Lechi A, Ghidini O, Dal Negro K, Cattini GC, Bezzi E. Efficacy and tolerance of cefuroxime axetil: an overview of the Italian experience. In: Program and abstracts of the Sixth Mediterranean Congress of Chemotherapy, Giardini Naxo, Italy. May 22 to 27, 1988, 646-7.
21. Hugonot R, Hugonot L, Pappo M, Chiche D. Ambulatory treatment with cefuroxime-axetil of patients aged sixty years and more with infectious bronchitis: a comparative "study with amoxicillin/clavulanic acid [in French]. Pathol Biol (Paris) 1990;38:533-7.
22. Camacho AE, Cobo R, Otte J, et al. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. Am J Med 1992;93:271-6.
23. Murray PR. Antimicrobial activity of seven oral antibiotics against selected community- and hospital-acquired pathogens. Clin Ther 1991;13:224-31.
24. Murray PR, Jones RN, Allen SD, et al. Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria. Diagn Microbiol Infect Dis 1993;16:191-203.
25. Washington JA, Jones RN, Gerlach EH, et al. Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime. Antimicrob Agents Chemother 1993;37:1696-700.
26. Jorgensen JH, Doern GV, Maher LA, et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
27. Harding SM, Williams PO, Ayrton J. Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteers. Antimicrob Agents Chemother 1984;25:78-82.
28. Williams PO, Harding SM. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food. J Antimicrob Chemother 1984;13:191-6.